Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CRY

CryoLife (CRY) Stock Price, News & Analysis

CryoLife logo

About CryoLife Stock (NYSE:CRY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$17.19
$21.72
52-Week Range
N/A
Volume
7,792 shs
Average Volume
198,221 shs
Market Capitalization
$703.22 million
P/E Ratio
596.20
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Receive CRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter.

CRY Stock News Headlines

Trump purposefully forcing markets to crash…
Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you ready for it?
Artivion price target raised to $35 from $32 at Lake Street
Artivion (AORT) Receives a Buy from Lake Street
See More Headlines

CRY Stock Analysis - Frequently Asked Questions

CryoLife, Inc. (NYSE:CRY) announced its earnings results on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.22. The medical equipment provider had revenue of $72.21 million for the quarter, compared to analyst estimates of $72.90 million. CryoLife had a net margin of 0.63% and a trailing twelve-month return on equity of 4.24%.

The following companies are subsidiaries of CryoLife: JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/04/2021
Today
4/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:CRY
Employees
1,200
Year Founded
1984

Profitability

Trailing P/E Ratio
596.20
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,680,000.00
Pretax Margin
0.41%

Debt

Sales & Book Value

Annual Sales
$253.23 million
Price / Cash Flow
23.30
Book Value
$8.46 per share
Price / Book
N/A

Miscellaneous

Free Float
37,560,000
Market Cap
$703.22 million
Optionable
Optionable
Beta
1.53

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:CRY) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners